49
In band
Moving averages
SMA 200$74.42-19.54%
Company profile
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
SectorHealthcare
IndustryBiotechnology
Market cap$9.51B
P/E ratioNone
EPS$-3.48
Beta0.4
Dividend yield0.00%
52-week high$86.74
52-week low$41.70
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 52
VRTX
Vertex Pharmaceuticals Inc
RSI 64
CRSP
CRISPR Therapeutics AG
RSI 54
IOVA
Iovance Biotherapeutics Inc
RSI 66
MRNA
Moderna Inc
RSI 64
VKTX
Viking Therapeutics Inc
RSI 44
SRPT
Sarepta Therapeutics Inc
RSI 66
EDIT
Editas Medicine Inc
RSI 52
NVAX
Novavax Inc
RSI 64
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 43
RSI alerts for IONS
Get an email the moment Ionis Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 2:45 AM EDT